標(biāo)簽化合物和放射藥物雜志出版原始科學(xué)手稿，涉及導(dǎo)致和導(dǎo)致標(biāo)簽化合物制備的所有方面的研究和開發(fā)。相關(guān)領(lǐng)域，如分析控制，自輻射分解，質(zhì)量控制，處理和存儲也包括在內(nèi)。有關(guān)化合物和示蹤劑方法在化學(xué)生化、生物藥理、醫(yī)學(xué)、遺傳、農(nóng)業(yè)和地球化學(xué)等方面的研究和應(yīng)用的論文也陸續(xù)發(fā)表。包括所有放射性核素和富集穩(wěn)定核素。目前，標(biāo)記化合物的制備和應(yīng)用幾乎遍及學(xué)術(shù)、醫(yī)學(xué)和工業(yè)科學(xué)研究的每一個(gè)領(lǐng)域。該雜志致力于報(bào)道多學(xué)科基礎(chǔ)上的新發(fā)展。主題范圍部分列表的主題包括：放射性核素的產(chǎn)生。回旋加速器制靶法。中子輻照方法。前驅(qū)體的制備和生產(chǎn)。合成(化學(xué)生化輻射同位素交換等)。核素生產(chǎn)前體制備與合成自動化。放射性和穩(wěn)定核素的分析(方法限制等，包括新的檢測技術(shù))。質(zhì)量控制(對有效數(shù)據(jù)的基本要求，特別是對放射性藥物)。自輻射分解穩(wěn)定性和儲存問題。與居里和多居里放射性物質(zhì)的生產(chǎn)和處理有關(guān)的特殊問題。與載流子問題有關(guān)的“同位素”稀釋及與穩(wěn)定核素和放射性核素使用有關(guān)的其他因素的理論和實(shí)踐。如果應(yīng)用程序的重點(diǎn)主要是標(biāo)記化合物的制備或使用的特殊方面，則歡迎提供應(yīng)用程序的手稿。為了在期刊上保持質(zhì)量和一致性的標(biāo)準(zhǔn)，審稿和評論提交給作者。

The Journal of Labelled Compounds and Radiopharmaceuticals publishes original scientific manuscripts dealing with all aspects of research and development leading to and resulting in labelled compound preparation. Related areas such as analytical control self radiolysis quality control handling and storage are also covered. Papers on compounds and tracer methods used in chemical biochemical biological pharmacological medical genetic agricultural and geochemical research and application also appear. All radionuclides and enriched stable nuclides are included. Preparation and application of labelled compounds now pervades almost every area of scientific research both academic medical and industrial. The Journal is devoted to reporting new developments from a multidisciplinary base. Range of Topics A partial list of topics includes: Radionuclide production. Cyclotron targetry. Neutron irradiation methodology. Precursor preparation and production. Synthesis (chemical biochemical radiation isotope exchange etc). Automation of nuclide production precursor preparation and synthesis. Analysis (methods limitations etc. for both radioactive and stable nuclides including new detection techniques). Quality control (an essential requirement for valid data and especially for radiopharmaceuticals). Self radiolysis stability and storage problems. Special problems relating to production and handling of Curie and multiCurie amounts of radioactivity. Theory and practice relating to carrier problems 'isotope' dilution and other factors concerning stable nuclide and radionuclide use. Manuscripts on applications are welcome where the focus is primarily on the preparation or special aspects of use of the labelled compound. Manuscripts are reviewed and comments submitted to authors in order to maintain standards of quality and uniformity in the Journal.